KR20080083044A - 트리테르펜퀴논 및 트리테르펜페놀 유도체와, 종양 및기생충성 질환의 치료를 위한 그 용도 - Google Patents

트리테르펜퀴논 및 트리테르펜페놀 유도체와, 종양 및기생충성 질환의 치료를 위한 그 용도 Download PDF

Info

Publication number
KR20080083044A
KR20080083044A KR1020087018837A KR20087018837A KR20080083044A KR 20080083044 A KR20080083044 A KR 20080083044A KR 1020087018837 A KR1020087018837 A KR 1020087018837A KR 20087018837 A KR20087018837 A KR 20087018837A KR 20080083044 A KR20080083044 A KR 20080083044A
Authority
KR
South Korea
Prior art keywords
alkyl
group
unsubstituted
substituted
independently hydrogen
Prior art date
Application number
KR1020087018837A
Other languages
English (en)
Korean (ko)
Inventor
후앙 카를로스 라칼 산후앙
아나 라미레즈 데 몰리나
모니카 바네즈 코로넬
앙헬 구티에레즈 라벨로
아나 에스테베즈 브라운
둘세 야즈민 메사 시베리오
엘리사 페레즈 사카우
Original Assignee
콘세호 수페리오르 데 인베스티가시오네스 시엔티피카스
유니버시다드 데 라 라구나
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 콘세호 수페리오르 데 인베스티가시오네스 시엔티피카스, 유니버시다드 데 라 라구나 filed Critical 콘세호 수페리오르 데 인베스티가시오네스 시엔티피카스
Publication of KR20080083044A publication Critical patent/KR20080083044A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
KR1020087018837A 2005-12-30 2006-12-29 트리테르펜퀴논 및 트리테르펜페놀 유도체와, 종양 및기생충성 질환의 치료를 위한 그 용도 KR20080083044A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503263A ES2277568B1 (es) 2005-12-30 2005-12-30 Derivados de triterpenoquinona y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
ESP200503263 2005-12-30

Publications (1)

Publication Number Publication Date
KR20080083044A true KR20080083044A (ko) 2008-09-12

Family

ID=37946257

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087018837A KR20080083044A (ko) 2005-12-30 2006-12-29 트리테르펜퀴논 및 트리테르펜페놀 유도체와, 종양 및기생충성 질환의 치료를 위한 그 용도

Country Status (11)

Country Link
EP (1) EP1976533A2 (es)
JP (1) JP2009522239A (es)
KR (1) KR20080083044A (es)
CN (1) CN101351211A (es)
AU (1) AU2006334359A1 (es)
BR (1) BRPI0620845A2 (es)
CA (1) CA2635318A1 (es)
ES (1) ES2277568B1 (es)
MX (1) MX2008008556A (es)
RU (1) RU2008131311A (es)
WO (1) WO2007077203A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012668A (es) 2005-04-13 2008-03-11 Consejo Superior Investigacion Metodo in vitro para identificar compuestos para terapia del cancer.
WO2009026163A1 (en) * 2007-08-17 2009-02-26 Burnham Institute For Medical Research Compositions and methods for inhibiting growth and metastasis of melanoma
CN101434635B (zh) * 2007-11-16 2012-05-16 上海华拓医药科技发展股份有限公司 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法
US20100068302A1 (en) * 2008-09-17 2010-03-18 Traslational Cancer Drugs Pharma, S.L. Methods and compositions for the treatment of cancer
WO2010049173A1 (en) * 2008-10-31 2010-05-06 Cenix Bioscience Gmbh Use of inhibitors of host kinases for the treatment of infectious diseases
JP2013536203A (ja) * 2010-08-23 2013-09-19 スーチョウ・ニューファーマ・カンパニー・リミテッド 特定の化学成分、組成物および方法
EP3364956A4 (en) 2015-10-23 2019-05-01 ERX Pharmaceuticals, Inc. CELASTROL ANALOGUES
US10808005B2 (en) 2016-07-04 2020-10-20 Ixmedicine (Xiamen) Biological Technology Company Limited Ligand for orphan nuclear receptor Nur77 and uses thereof
WO2018019681A1 (en) 2016-07-25 2018-02-01 Nerviano Medical Sciences S.R.L. Purine and 3-deazapurine analogues as choline kinase inhibitors
EP3652177A1 (en) 2017-07-11 2020-05-20 Nerviano Medical Sciences S.r.l. Pyrazolo-quinazoline derivatives as choline kinase inhibitors
WO2020257658A1 (en) 2019-06-20 2020-12-24 University Of Iowa Research Foundation Nanoparticles comprising quinone w methides and compositions for use
CN113827599A (zh) * 2021-09-23 2021-12-24 天津国际生物医药联合研究院 去甲泽拉木醛在抗登革病毒感染中的潜在应用
CN116023426A (zh) * 2022-12-30 2023-04-28 上海海洋大学 去甲泽拉木醛衍生物及其在制备抗癌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328309A (en) * 1980-07-02 1982-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method for producing tripdiolide, triptolide and celastrol
DE4117854A1 (de) * 1991-05-31 1992-12-03 Wiemann Wolfram Verwendung mindestens eines celastroloids als bestandteil fuer ein arzneimittel zur behandlung von erkrankungen des rheumatoiden formenkreises, insbesondere rheumatismus
US5650167A (en) * 1995-11-16 1997-07-22 Dawa Incorporated Method and composition for treating hepatitis B
ES2117950B1 (es) 1996-08-02 1999-09-16 Univ Granada Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.
CN1155610C (zh) * 2002-11-05 2004-06-30 浙江大学 具有抗氧化和抗肿瘤活性扁蒴藤素系列衍生物及合成方法
US20040220267A1 (en) * 2003-02-07 2004-11-04 Devlin J. P. Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases

Also Published As

Publication number Publication date
JP2009522239A (ja) 2009-06-11
ES2277568A1 (es) 2007-07-01
CA2635318A1 (en) 2007-07-12
ES2277568B1 (es) 2008-04-01
EP1976533A2 (en) 2008-10-08
WO2007077203A2 (en) 2007-07-12
AU2006334359A1 (en) 2007-07-12
BRPI0620845A2 (pt) 2011-11-22
WO2007077203A3 (en) 2007-08-30
AU2006334359A2 (en) 2008-08-07
CN101351211A (zh) 2009-01-21
MX2008008556A (es) 2008-09-26
RU2008131311A (ru) 2010-02-10

Similar Documents

Publication Publication Date Title
KR20080083044A (ko) 트리테르펜퀴논 및 트리테르펜페놀 유도체와, 종양 및기생충성 질환의 치료를 위한 그 용도
Cao et al. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
JP7098609B2 (ja) ピリジン化合物
Tan et al. Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives
CN110526916B (zh) 氘代Capmatinib化合物及其用途
KR20230153533A (ko) 유로리틴 유도체 및 이의 사용 방법
WO2022199547A1 (zh) 一种7,9-二氢嘌呤衍生物及其制药用途
EP3418277B1 (en) Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof
CN110156822B (zh) 一种萘酚-苯硼酸类化合物及其制备方法和用途
JP2019523230A (ja) 抗転移性２Ｈ‐セレノフェノ［３，２‐ｈ］クロメン、それらの合成、および同薬剤の使用方法
JP7245918B2 (ja) サルササポゲニン構造に基づく誘導体、医薬組成物及びその使用
KR100195421B1 (ko) 6-아미노옥타히드로인돌리진트리올유도체
KR20200022759A (ko) 신규한 벤조파이란 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 약학적 조성물
Perez et al. Synthesis and biological evaluation of new securinine analogues as potential anticancer agents
KR101208956B1 (ko) 엘로티닙 다이클로로아세트산염 및 이를 포함하는 항암제 조성물
Kang et al. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia
CN106188211B (zh) 白桦脂酸衍生物及其应用
CN111393500B (zh) 具有共轭二烯结构c环的齐墩果酸衍生物及其制备方法和应用
CA2636040C (en) Metabolites of wortmannin analogs and methods of using the same
CN116096372A (zh) 一种egfr抑制剂、其制备方法和在药学上的应用
CN112279863A (zh) Hsp90抑制剂与喜树碱衍生物的偶联物及其制备方法与应用
KR102421065B1 (ko) 새로운 퀴논-인돌리진 하이브리드 유도체 제조방법 및 이를 포함하는 항암제 조성물
US11319328B2 (en) 4β-amino substituted podophyllotoxin derivative and preparation method therefor and use thereof
CN106117304B (zh) 白桦脂酸衍生物
WO2021139740A1 (zh) 四氢***酚衍生物及其制备方法和在医药上的应用

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid